Inside The Startup Reinventing The $6 Trillion Chemical Manufacturing Industry

Solugen co-founders Gaurab Chakrabarti and Sean Hunt explain how a pancreatic cancer enzyme discovery became a billion-dollar chemioenzymatic manufacturing platform.

• Solugen’s core process pairs enzymes from pancreatic cancer cells with metal catalysts, achieving 96% yield vs. ~60% in conventional chemical plants.
• Feedstock is corn syrup (sugar), not oil and gas, eliminating fossil-fuel-derived toxic byproducts across their product line.
• First reactor cost $7K–$10K in PVC pipe from Home Depot; at peak it generated $12,000/month in revenue from hot tub and float spa owners.
• To land their first oil-and-gas customer, they bought billboards along one specific buyer’s commute for $10K–$15K until he called them.
• Bioforge plant holds 800,000 lb of corn syrup and produces 2–4 tanker trucks of product from a single Coke bottle of enzyme — same bubble-column design as the PVC prototype, just 10,000 gal instead of 7.
• YC framed as ‘grad school for customers’: understanding customer economics precisely told them exactly what to build and what to skip.
• Solugen’s competitive edge over Dow-scale incumbents is small, customer-proximate plants that cut shipping costs and enable margins incumbents can’t match.

2026-03-20 · Watch on YouTube